» Articles » PMID: 28356657

Obesity and Kidney Disease: Hidden Consequences of the Epidemic

Overview
Specialty Nephrology
Date 2017 Mar 31
PMID 28356657
Citations 24
Authors
Affiliations
Soon will be listed here.
Citing Articles

Exploring the interplay between kidney function and urinary metabolites in young adults: the African-PREDICT study.

du Toit W, Kruger R, Gafane-Matemane L, Schutte A, Louw R, Mels C Amino Acids. 2024; 56(1):53.

PMID: 39207612 PMC: 11362211. DOI: 10.1007/s00726-024-03412-7.


Long-Term Protective Effects and Mechanisms of Gastric Bypass Surgery on the Kidneys in Hypertensive Obese Rat.

Zhang Y, Kong X, Song K, He M, Xian Y, Xie X Obes Surg. 2024; 34(4):1257-1266.

PMID: 38396260 DOI: 10.1007/s11695-024-07108-5.


Renal Endocannabinoid Dysregulation in Obesity-Induced Chronic Kidney Disease in Humans.

Permyakova A, Rothner A, Knapp S, Nemirovski A, Ben-Zvi D, Tam J Int J Mol Sci. 2023; 24(17).

PMID: 37686443 PMC: 10487429. DOI: 10.3390/ijms241713636.


Neutralizing MIP3 Reduces Renal Immune Cell Infiltration and Progressive Renal Injury in Young Obese Dahl Salt-Sensitive Rats.

Ekperikpe U, Poudel B, Shields C, Mandal S, Cornelius D, Williams J J Pharmacol Exp Ther. 2022; 384(3):445-454.

PMID: 36507846 PMC: 9976792. DOI: 10.1124/jpet.122.001298.


Reduction in Serum Magnesium Levels and Renal Function Are Associated with Increased Mortality in Obese COVID-19 Patients.

Pulido Perez P, Pondigo de Los Angeles J, Perez Peralta A, Ramirez Mojica E, Torres Rasgado E, Hernandez-Hernandez M Nutrients. 2022; 14(19).

PMID: 36235704 PMC: 9571102. DOI: 10.3390/nu14194054.


References
1.
Iseki K, Ikemiya Y, Kinjo K, Inoue T, Iseki C, Takishita S . Body mass index and the risk of development of end-stage renal disease in a screened cohort. Kidney Int. 2004; 65(5):1870-6. DOI: 10.1111/j.1523-1755.2004.00582.x. View

2.
Kalantar-Zadeh K, Kuwae N, Wu D, Shantouf R, Fouque D, Anker S . Associations of body fat and its changes over time with quality of life and prospective mortality in hemodialysis patients. Am J Clin Nutr. 2006; 83(2):202-10. DOI: 10.1093/ajcn/83.2.202. View

3.
Ruster C, Wolf G . The role of the renin-angiotensin-aldosterone system in obesity-related renal diseases. Semin Nephrol. 2013; 33(1):44-53. DOI: 10.1016/j.semnephrol.2012.12.002. View

4.
Foster M, Hwang S, Massaro J, Hoffmann U, deBoer I, Robins S . Association of subcutaneous and visceral adiposity with albuminuria: the Framingham Heart Study. Obesity (Silver Spring). 2010; 19(6):1284-9. PMC: 3096746. DOI: 10.1038/oby.2010.308. View

5.
Vivante A, Golan E, Tzur D, Leiba A, Tirosh A, Skorecki K . Body mass index in 1.2 million adolescents and risk for end-stage renal disease. Arch Intern Med. 2012; 172(21):1644-50. PMC: 4941233. DOI: 10.1001/2013.jamainternmed.85. View